Antihypertensive and hemodynamic properties of 2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine HCl (MK-761).
D000818:Animals; D000959:Antihypertensive Agents; D001013:Aorta, Thoracic / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002521:Cercopithecus; D004285:Dogs; D005260:Female; D000882:Haplorhini; D006439:Hemodynamics / Q000187:drug effects*; D006973:Hypertension / Q000503:physiopathology; D006977:Hypertension, Renal / Q000503:physiopathology; D066298:In Vitro Techniques; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008297:Male; D011725:Pyridines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D014665:Vasodilator Agents
D000959:Antihypertensive Agents; D011725:Pyridines; D014665:Vasodilator Agents; C021276:MK 761